NCT07072143Recruiting
An International Study on Pediatric Patients With Rare Tumors.
The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
Source: ClinicalTrials.gov · Last updated 18 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6250 (estimated)
- First submitted
- 15 Apr 2025
- Start date
- Jan 2025
- Primary completion date
- Jan 2049
- Lead sponsor
- Azienda Ospedaliera di Padova
- NCT number
- NCT07072143
What you commit to
- Study type: Observational
- Planned participants: 6250
- From Jan 2025 to the primary completion date, Jan 2049
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Absence of Written informed consent from the patient and/or the parent/legal guardian
Who the study is looking for
- Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
- Written informed consent from the patient and/or the parent/legal guardian
Age in the registry: 0 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova] Coordinator of this site? Confirm its status | Padova | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.